Attached files
| file | filename |
|---|---|
| EX-10.2 - FORM OF CITIUS 2014 STOCK INCENTIVE PLAN NONQUALIFIED STOCK OPTION - Citius Pharmaceuticals, Inc. | ctxr_ex102.htm |
| EX-31.1 - CERTIFICATION - Citius Pharmaceuticals, Inc. | ctxr_ex311.htm |
| EX-10.1 - 2014 STOCK INCENTIVE PLAN - Citius Pharmaceuticals, Inc. | ctxr_ex101.htm |
| 10-Q - FORM 10-Q - Citius Pharmaceuticals, Inc. | ctxr_10q.htm |
EXHIBIT 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Citius Pharmaceuticals, Inc. (the "Company") on Form 10-Q for the period ended June 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Myron Holubiak, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: August 15, 2016 | By: | /s/ Myron Holubiak | |
Myron Holubiak | |||
Chief Executive Officer, | |||
Principal Executive Officer and Principal Financial Officer |